Assyro AI

Orange Book product · Brand (NDA)

GLEEVEC

IMATINIB MESYLATE

Brand (NDA)NDA 021588TE ABRX NOVARTIS
View IMATINIB MESYLATE familyOpen on FDA Orange Book

At a glance

Apr 18, 2003

Approved

Brand (NDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 18, 2003

    23 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

IMATINIB MESYLATE

Strength

EQ 100MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

NDA 021588

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo